Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6564 stock hub

TPEX/6564 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6564is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6564

In the news

Latest news · TPEX/6564

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-52.3

P25 -16.2P50 0.3P75 9.8

ROIC-25.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6564 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

TWD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	38
Employees Change	9%
Employees Change Percent	31.03
Enterprise value	TWD 1.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006564008
Last refreshed	2026-05-10
Market cap	TWD 1.4B
Price	TWD 18.95
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6564
Website	https://www.enimmune.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.02%
EV Earnings	-7.99x
EV/FCF	-8.9x
EV/Sales	27.23x
FCF yield	-10.79%
P/B ratio	9.13x
P/S ratio	28.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	16.63%
Gross Profit	TWD 8M
Gross Profit Growth	-43.45%
Gross Profit Growth5 Y	-14.33%
Net Income	TWD -164.3M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-341.41%
ROA	-19.63
Roa5y	-17.51
ROCE	-101.6
ROE	-52.33
Roe5y	-36.65
ROIC	-25.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.37%
Cagr3y	-28.22%
Cagr5y	-20.57%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	20.74x
Revenue Growth Q	30.44x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.75x
Revenue Growth5 Y	-15.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.08
Assets	TWD 456.1M
Cash	TWD 225.8M
Current Assets	TWD 318.2M
Current Liabilities	TWD 273.7M
Debt	TWD 171.2M
Debt Equity	TWD 1.14
Debt FCF	TWD -1.16
Equity	TWD 149.7M
Interest Coverage	-46.16
Liabilities	TWD 306.4M
Long Term Assets	TWD 137.9M
Long Term Liabilities	TWD 32.7M
Net Cash	TWD 54.6M
Net Cash By Market Cap	TWD 3.99
Net Cash Growth	-85.71%
Net Debt Equity	TWD -0.36
Tangible Book Value	TWD 50.6M
Tangible Book Value Per Share	TWD 0.7
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.16
Inventory Turnover	1.41
Net Working Capital	TWD -42.8M
Quick ratio	0.99
Working Capital	TWD 44.5M
Working Capital Turnover	TWD 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.37%
200-day SMA	19.33
3Y total return	-63.02%
50-day SMA	18.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.38%
All Time High	125
All Time High Change	-84.84%
All Time High Date	2020-07-06
All Time Low	14.49
All Time Low Change	30.78%
All Time Low Date	2020-03-19
ATR	0.8
Beta	0.33
Beta1y	0.12
Beta2y	0.38
Ch YTD	-8.01
High	18.95
High52	23.9
High52 Date	2025-10-23
High52ch	-20.71%
Low	18.4
Low52	14.65
Low52 Date	2025-07-17
Low52ch	29.35%
Ma50ch	3.48%
Price vs 200-day SMA	-1.95%
RSI	52.14
RSI Monthly	35.69
RSI Weekly	47.38
Sharpe ratio	0.19x
Sortino ratio	0.51
Total Return	-0.86%
Tr YTD	-8.01
Tr1m	2.71%
Tr1w	-0.26%
Tr3m	-4.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -185.2M
Operating margin	-384.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,849,978%
Net Borrowing	53,210,000
Shares Insiders	0.74%
Shares Institutions	3.87%
Shares Out	72,134,000
Shares Qo Q	0%
Shares Yo Y	0.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -149.2M
Average Volume	123,088.6x
Bv Per Share	2.08
CAPEX	TWD -4.2M
Ch1m	2.71
Ch1w	-0.26
Ch1y	7.37
Ch3m	-4.53
Ch3y	-63.06
Ch5y	-68.42
Ch6m	-8.01
Change	0%
Change From Open	0.53
Close	18.95
Days Gap	-0.53
Depreciation Amortization	6,024,000
Dollar Volume	2,279,343.9
Earnings Date	2026-08-11
EBIT	TWD -185.2M
EBITDA	TWD -179.2M
EPS	TWD -2.28
F Score	2
FCF	TWD -147.4M
FCF EV Yield	-11.23x
FCF Per Share	TWD -2.04
Financing CF	-103,098,000
Fiscal Year End	December
Founded	2,014
Investing CF	-25,750,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	19.84
Ma150ch	-4.46%
Ma20	18.93
Ma20ch	0.12%
Net CF	-282,518,000
Next Earnings Date	2026-08-11
Open	18.85
Position In Range	100
Ppne	14,140,000
Price Date	2026-05-08
Ptbv Ratio	27.01
Relative Volume	0.98x
Revenue	48,194,000x
SBC By Revenue	3.64x
Share Based Comp	1,752,000
Tr6m	-8.01%
Volume	120,282
Z Score	-0.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6564 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6564 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6564?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.9%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

TPEX/6564 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

-2.0%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6564

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6564 stock rating?

tpex/6564 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6564 analysis?

The full report lives at /stocks/tpex/6564/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6564?

The latest report frames tpex/6564 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6564 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.